Tarsa Therapeutics, Inc
Pioneering an oral solution for osteoporosis with a hormone that reduces bone degradation.
Philadelphia, United States
3 employees
Debt Financing
Total: $124.25M
Biotechnology, Medical Devices
General Information
Philadelphia, United States
BounceWatch is an independent company data service, not affiliated with Tarsa Therapeutics, Inc. To contact Tarsa Therapeutics, Inc, visit tarsatherapeutics.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
United States Market
Biotechnology
About Tarsa Therapeutics, Inc
Taxonomy: Tarsa Therapeutics, osteoporosis treatment, oral solution, calcitonin, bone degradation, peptide hormone, bone destruction, pharmaceutical development, osteoporosis therapy, medical advancement
Funding Rounds & Investors (9)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Debt Financing | $1.20M | - |
|
15 Jul 2016 |
| Debt Financing | $2.00M | - |
|
19 Feb 2016 |
| Debt Financing | $10.00M | 2 |
|
13 Aug 2014 |
| Series B | $7.00M | 4 |
|
29 May 2014 |
| Series B | $28.00M | 5 |
|
16 Mar 2012 |
| Venture Round | $24.50M | - |
|
12 Jul 2011 |
| Debt Financing | $15.50M | - |
|
21 Apr 2011 |
| Series A | $24.00M | 3 |
|
17 Jan 2010 |
| Venture Round | $12.05M | - |
|
23 Oct 2009 |
Tarsa Therapeutics, Inc Alternatives & Competitors
View All Alternatives
Delivering the promise of radiopharmaceuticals to patients.
SOLIUS® Medical Light Therapy
CSA Medical, Inc. develops and manufactures the RejuvenAir System, a proprietary interventional liqu...
FAQ About Tarsa Therapeutics, Inc
Source: BounceWatch company record for Tarsa Therapeutics, Inc, https://bouncewatch.com/company/tarsa-therapeutics-inc, updated 28 October 2024. When citing, please name BounceWatch and link this page.
